Granulocyte-macrophage colony-stimulating factor (GM-CSF) induced apoptosis in human hematopoietic U937 cells by itself and in a synergistic manner with tumor necrosis factor (TNF). GM-CSF-induced apoptosis was not inhibited by caspase inhibitors YVAD-CMK, DEVD-CHO and z-VAD-FMK, under the condition that these inhibitors potently suppressed TNFinduced apoptosis. Both GM-CSF and TNF induced caspase 3-like activity in this cell line though the time course was distinct between two cytokines, and combined stimulation of cells with GM-CSF plus TNF induced additive or synergistic activation of caspase 3-like activity. Amount of immunoreactive cleaved forms of caspase 3 recognized by specific antibody was completely dissociated with its enzymatic activity when the cells were stimulated with GM-CSF, but not with TNF. These results indicate that GM-CSF induces apoptosis of U937 cells via unknown pathway, which seems to be mediated by caspase 3-like activity, yet not caspase 3 itself, resistant to the caspase inhibitors, and synergistically interacts with conventional caspase 3 pathway of TNF. Possible involvement of caspases 1 and 8 (-like activity) but not caspase 7 in this pathway was also suggested. Leukemia (2000) 14, 612-619.
Introduction
Apoptosis is a way of cell death that is programmed genetically and occurs actively. Detailed analyses for this phenomenon have been performed and its important roles in a wide variety of biological systems have been determined. 1 In addition to these physiological significances, intracellular signaling mechanisms of apoptosis have also been intensively studied. Among the signaling molecules for apoptosis, caspase 3 (CPP32) has been reported to play critical roles 2, 3 and its direct downstream target seems to be DNase which induces the internucleosomal fragmentation of DNA. 4 Granulocyte-macrophage colony-stimulating factor (GM-CSF) is one member of hematopoietic growth factors that supports the proliferation and/or differentiation of hematopoietic cell. 5 GM-CSF is known to activate signaling molecules such as Stat5 and extracellular-regulated kinase (ERK) to exert these biological effects. 6, 7 Although this factor is well known to induce the proliferation and inhibit apoptosis, [5] [6] [7] its possible apoptosis-inducing effects on hematopoietic cells have not been well characterized. In addition, its effects on caspases are largely unknown.
In the present study, we investigated the apoptosis-inducing effects of GM-CSF on human hematopoietic cell line in comparison with those of TNF, and extended the study to the intracellular signaling pathways linking to apoptosis, caspase cascade. Results indicate that GM-CSF induces apoptosis of 
Materials and methods

Reagents
Highly purified recombinant human GM-CSF and TNF produced by Escherichia coli were provided by Schering Plough, Osaka, Japan and Dainippon Pharmaceutical, Osaka, Japan, respectively. Contamination of lipopolysaccharide was less than 100 pg/mg protein, as determined by limulus amebocyte lysate assay. Sodium dodecyl sulfate (SDS), dimethyl sulfoxide (DMSO), RNase, ethidium bromide, Marker 4 and the tetrapeptide caspase 1 inhibitor, acetyl-Tyr-Val-Ala-Asp-chloromethylketone (YVAD-CMK) were purchased from Wako Pure Chemical, Tokyo, Japan. RPMI 1640 medium was from Gibco Laboratories, Grand Island, NY, USA; fetal calf serum from JRH Bioscience, Lenexa, KS, USA; Proteinase K from Boehringer Mannheim, Mannheim, Germany; BCA protein assay reagent from Pierce, Rockford, IL, USA; a fluorogenic substrate for caspase 7, amino-methylcumarin-Val-Asp-Gln-ValAsp-Gly-Trp-[Lys-DNP] (AMC-VDQVDGW[K-DNP]), from Calbiochem-Novabiochem, La Jolla, CA, USA; fluorogenic substrates for caspase 1, acetyl-Tyr-Val-Ala-Asp-aminomethylcumarin (YVAD-AMC), caspase 3, acetyl-Asp-Glu-ValAsp-amino-methylcumarin (DEVD-AMC), and caspase 8, acetyl-Ile-Glu-Thr-Asp-amino-methylcumarin (IETD-AMC), and the tetrapeptide caspase 3 inhibitor, acetyl-Asp-Glu-Val-Asp (aldehyde) (DEVD-CHO) and the tripeptide caspase inhibitor, carbobenzoxy Val-Ala-Asp-fluoromethylketone (z-VAD-FMK) were from Peptide Institute, Osaka, Japan. The monoclonal anti-caspase 3 antibody was purchased from Transduction Laboratories, Lexington, KY, USA; monoclonal anti-caspase 1 antibody from Pharmingen, San Diego, CA, USA; polyclonal anti-caspase 7 and caspase 8 antibodies were from Santa Cruz Biotechnology, Santa Cruz, CA, USA; alkaline phosphataseconjugated anti-mouse IgG and alkaline phosphatase-conjugated anti-rabbit IgG antibodies from Promega, Madison, WI, USA; and nitrocellulose membrane and protein A-Sepharose from BioRad, Richmond, CA, USA. Other reagents for the cell culture, FACS analysis, DNA fragmentation assay, determination of caspase activity, Western blotting and immunoprecipitation were purchased from Sigma Chemical, St Louis, MO, USA.
Culture and preparation of cells
U937 cells were grown in RPMI 1640 medium supplemented with 10% heat-inactivated fetal calf serum, penicillin (100 U/ml) and streptomycin (100 g/ml). For the induction of apoptosis, U937 cells were seeded at 4-8 × 10 4 cells/ml and grown in the presence or absence of cytokines and other agents for up to 4 days. Cultured cells were harvested after the cultivation with these agents, washed one to three times with phosphate-buffered saline (PBS), and then suspended in appropriate buffer for each experiment.
FACS analysis
FACS analysis for determination of cell cycle distribution was performed as described. 8 After exposure to appropriate stimuli, cells were washed in PBS once, and then resuspended in 80% ice-cold ethanol for fixing. After treatment with RNase (100 g/ml) for 30 min at 37°C, DNA was stained with 50 g/ml of propidium iodide. Cell cycle analysis was performed by FACScan (Nippon Becton Dickinson, Tokyo, Japan), and the number of cells in the area corresponding to the sub-G1 region was calculated using the Lysis II program (Nippon Becton Dickinson).
Morphological evaluation of cells
Light microscopic examination of cell viability and morphology was done to determine the apoptosis of U937 cells. For the determination of cell viability, a cell count was made on the hemocytometer using the trypan blue dye exclusion test. For the morphological evaluation of apoptosis, cells suspended in Hanks' balanced salt solution (HBSS) were caused to adhere to slide glasses by centrifugation using Cytospin 2 (Shandon, Pittsburgh, PA, USA) and cytospin slides were then subjected to Wright-Giemsa staining for light microscopic examination of the cells.
DNA fragmentation assay
Small molecular weight chromosomal DNA from the nucleus and cytoplasm was prepared as described. 9 Briefly, 3 × 10 6 cells were lysed with 350 l of lysis buffer containing 0.6% SDS and 1 mM EDTA (pH 8.0), and after 5 min incubation at room temperature, 95 l of 5 M NaCl was added. This was mixed gently and incubated for more than 8 h at 4°C. It was then centrifuged at 20 000 g for 20 min at 4°C, and the supernatant was further incubated with 1 mg/ml of heat inactivated RNase A for 90 min at 45°C, and with 2 mg/ml of proteinase K for another 60 min. After phenol-extraction, phenol/ chloroform-extraction and ethanol precipitation, one third of the DNA sample was applied on 2% agarose gel, separated by horizontal electrophoresis, and visualized by staining with ethidium bromide (500 ng/ml). Marker 4 was used for evaluation of the molecular weights of the fragmented DNA.
Determination of caspase activity
Caspase activity was measured by the method reported previously. 10 Cells were washed in PBS and resuspended in 350 l of the lysis buffer composed of 20 M digitonin, 50 mM Tris-HCl (pH 7.5), 1 mM EDTA and 10 mM EGTA. After incubation of cells in the lysis buffer for 10 min at 37°C, the samples were centrifuged at 20 000 g for 5 min. The protein concentration of each sample was measured using BCA protein assay reagent. The fluorescent peptides conjugated with 7-amino-4-methylcoumarin (AMC), DEVD-AMC, YVAD-AMC, IETD-AMC and AMC-VDQVDGW[K-DNP], were used Leukemia as substrates for caspase 3-, 1-, 8-and 7-like activities, respectively. An aliquot of each sample was incubated with the substrate for 1 h at 37°C. The release of AMC was measured by a fluorescence microplate reader, model MTP-100F (Corona Electric, Hitachi, Ibaragi, Japan) or Hitachi F-4010 fluorescence spectrophotometer (Hitachi, Tokyo, Japan). The excitation and emission wavelengths were set at 360 and 450 nm for caspase 3-like activity, 380 and 460 nm for caspase 1-and 8-like activities, and 316 and 394 nm for caspase 7-like activity, respectively. The sample composed of substrate and lysis buffer was used as blank. Caspase activity was measured as fluorescence units normalized by the protein concentration in the samples.
Preparation of cell lysate for Western blotting and immunoprecipitation
For Western blotting, the cell pellets were resuspended in icecold solution containing 50 mM Hepes (pH 7.4), 2 mM sodium orthovanadate, 100 mM sodium fluoride, 1 mM EDTA, 1 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin and 10 g/ml leupeptin. The cell suspension was mixed with 1:1 with 2 × sample buffer (4% SDS, 20% glycerol, 10% mercaptoethanol and a trace amount of bromophenol blue dye in 125 mM Tris-HCl, pH 6.8), heated for 5 min at 100°C and then frozen at −80°C until use. For immunoprecipitation, the cell pellets were resuspended in ice-cold solution containing 50 mM Hepes (pH 7.4), 1% Triton X-100, 2 mM sodium orthovanadate, 100 mM sodium fluoride, 1 mM EDTA, 1 mM EGTA, 1 mM phenymethylsufonyl fluoride, 10 g/ml aprotinin and 10 g/ml leupeptin, and lysed for 20 min at 4°C. Insoluble materials were removed by centrifugation for 15 min at 4°C.
Western blotting
Samples were subjected to 10% or 14% SDS polyacrylamide gel electrophoresis. After electrophoresis, proteins were electrophoretically transferred from the gel on to a nitrocellulose membrane in a buffer containing 25 mM Tris, 192 mM glycine and 20% methanol at 2 mA/cm 2 for 2 h at 4°C. Residual binding sites on the membrane were blocked by incubating the membrane in Tris-buffer (150 mM Tris-HCl, pH 7.6) containing 3% bovine serum albumin for 1 h at 25°C. The blots were then washed in PBS containing 0.05% Tween 20. For Western blotting of caspases 3 and 1, the membranes were incubated with monoclonal anti-caspase 3 or anti-caspase 1 antibody for 4 h at 25°C. The primary antibody was removed and the blots were washed three times in PBS containing 0.05% Tween 20. To detect antibody reactions, the blots were incubated for 2 h with alkaline phosphatase-conjugated anti-mouse IgG antibody diluted 1:2000 in Tris-buffer containing 1% bovine serum albumin, washed three times with PBS containing 0.05% Tween 20, and then placed in a buffer containing 100 mM Tris-HCl (pH 9.7), 5 mM MgCl 2 , 10 M ZnCl 2 , 200 g/ml nitroblue tetrazolium and 200 g/ml 5-bromo-4-chloro-3-indolyphosphate for 10 to 30 min at 25°C. Enzymatic color development was stopped by rinsing the membranes in deionized water. For Western blotting of caspase 8, the membranes were sequentially incubated with a polyclonal anti-caspase 8 antibody and alkaline phosphatase-conjugated anti-rabbit IgG antibody. For Western blotting of caspase 7, the membranes were sequentially incubated with a polyclonal anti-caspase 7 antibody and alkaline phosphatase-conjugated anti-goat IgG antibody. After each incubation, enzymatic color development was performed as described above.
Immunoprecipitation
The total cell lysates were precleared with protein ASepharose for 1 h at 4°C. The precleared lysates were then incubated with a monoclonal anti-caspase 3 antibody, and the immune complexes were collected using protein ASepharose. All of the immunoprecipitates were intensively washed with ice-cold solution containing 50 mM Hepes (pH 7.4), 1% Triton X-100, 150 mM NaCl, 0.1% SDS, 2 mM sodium orthovanadate, 100 mM sodium fluoride, 1 mM EDTA, 1 mM EGTA, 1 mM phenylmethylsulfonyl fluoride, 10 g/ml aprotinin and 10 g/ml leupeptin.
Statistical analysis
The Student's t-test was used to determine statistical significance.
Results
Induction of apoptosis by GM-CSF in human hematopoietic U937 cells
In the initial experiment, we performed FACS analysis for cell cycle phase determination to study whether GM-CSF, a growth stimulating cytokine for hematopoietic cells, could potentially induce change in cell cycle distribution in human myeloid cells by using U937 cell line. As shown in Figure 1a , GM-CSF induced minimal changes in cell cycle distribution including G1, S and G2/M in U937 cells. Unexpectedly, GM-CSF-stimulated cells showed increased population of sub-G1 region (a hypodiploid DNA peak), suggesting that GM-CSF induced apoptosis in this cell line during the in vitro culture since cells undergoing apoptosis were often recognized as an accumulated cell population in sub-G1 region. 8 GM-CSF induced increment of sub-G1 population of U937 cells in a time-dependent manner. Significant increase (P Ͻ 0.05) was obtained at 48 h (2 days) and the cellular response was potentiated dramatically at 96 h (4 days) (Figure 1b) . This response was dependent on the concentrations of GM-CSF used as stimulus and the maximal effect was observed at 1 to 10 ng/ml GM-CSF (data not shown).
To further confirm that observed increase in sub-G1 population induced by GM-CSF in U937 cells was due to apoptosis, we performed morphological examination of cells by light microscopy and determined DNA fragmentation of cells by using agarose gel electrophoresis of small molecular weight DNA extracted from U937 cells. As shown in Figure 1c and d, cultivation of U937 cells with GM-CSF for 4 days potently induced morphological changes (cells with condensed nuclei, so-called apoptotic bodies) and DNA fragmentation (DNA ladder formation) in this cell line as compared with cells cultured without GM-CSF. Thus, GM-CSF did induce not only increase in sub-G1 fraction (decrease in DNA content) but also morphological change characteristic for apoptosis and DNA fragmentation in some population of U937 cells.
Synergistic induction of apoptosis by the combination of GM-CSF plus TNF
In addition to GM-CSF, TNF increased the cell population corresponding to sub-G1 region in U937 cells (Figure 2 ), and this phenomenon was confirmed as apoptosis by DNA ladder formation (data not shown). This finding is consistent with the findings for this cell line reported from our and other laboratories. 9, 11 An apoptosis-inducing effect of the optimal concentration of TNF (10 ng/ml) was rapid and potent, and maximal effect was obtained at 2 days of incubation with TNF, when apoptosis by GM-CSF was significant (Figure 1b) but only minimal. Under these conditions, potent apoptosis-inducing effect of TNF was further potentiated by the simultaneous addition of GM-CSF with TNF ( Figure 2 ). This finding indicates synergistic interaction of the intracellular events triggered by the optimal concentrations of the two cytokines, suggesting their distinct mechanisms to induce apoptosis.
Time courses of cell proliferation of U937 cells as determined by viable cell count confirmed more delayed effect of GM-CSF than TNF, and indicated more profound growth suppression by the combination of the two cytokines than by TNF alone (Figure 3) .
Caspase 3-like activity induced by GM-CSF and TNF
Recent progress in intracellular signaling pathway after TNF receptor to apoptosis indicates involvement of stepwise cascade of several intracellular caspases.
2,3 Particularly, caspase 3 seems to be a key enzyme regulating apoptosis. 3, 4 To test the involvement of caspase 3 in GM-CSF-induced apoptosis, we determined whether GM-CSF induced increment of caspase 3-like activity in human U937 cells in comparison with TNF. Involvement of caspase was directly studied by measuring caspase activity using a fluorescent substrate, DEVD-AMC.
As shown in Figure 4 , baseline level of caspase 3-like activity did not show detectable change during the 96 h (4 days) cultivation of U937 cells. TNF induced rapid potentiation of caspase 3-like activity, and its maximal activation occurred and continued at 6-48 h of incubation with TNF. Enzymatic activity of caspase 3 declined considerably at 72 h and was not detected at 96 h when the cells were stimulated with TNF.
GM-CSF also did induce caspase 3-like activity. In contrast to TNF, caspase 3-like activity triggered by GM-CSF showed prolonged and gradual time courses. Enzymatic activity stimulated by GM-CSF was detected at 24 h and it greatly increased at 72 to 96 h. This pattern of time course is in parallel with that of apoptosis ( Figure 1b ) and growth suppression (Figure 3 ). Combined stimulation of cells with GM-CSF plus TNF exerted additive or synergistic effect on caspase 3-like activity.
To further confirm that caspase 3-like activity induced by GM-CSF was really DEVDase, we studied the effects of membrane permeable inhibitor of DEVDase (DEVD-CHO) on caspase 3-like activity induced by GM-CSF. As shown in Figure 5 , high concentration of DEVD-CHO almost completely abolished increment of caspase 3-like activity induced by GM-CSF. Interestingly and unexpectedly, membrane permeable inhibitor of YVADase (YVAD-CMK) also inhibited caspase 3-like activity induced by GM-CSF ( Figure 5 ). Another caspase inhibitor, z-VAD-FMK, which has a broad spectrum of activity, potently inhibited caspase 3-like activity induced by GM-CSF ( Figure 5 ). Induction of apoptosis by GM-CSF in U937 cells. (a) FACS analysis of U937 cells with or without GM-CSF. Human hematopoietic U937 cells were cultivated with or without 10 ng/ml GM-CSF for 4 days (96 h), and then subjected to FACS analysis to determine cell cycle distribution. The population in the sub-G1 region was indicated as percentage of total cells. (b) Time courses of cell number in sub-G1 region in U937 cells during 96 h (4 days) cultivation. The population in the sub-G1 region was quantified in each time point of the culture with or without 10 ng/ml GM-CSF. The data are expressed as means ± s.d. of three to eight experiments. (c) Morphology of U937 cells with or without GM-CSF. U937 cells were cultivated with or without 10 ng/ml GM-CSF for 4 days, and then cytospin specimen of the cells were prepared to determine the morphological characteristics of the apoptosis. Arrowhead cells exhibit typical morphology of so-called 'apoptotic body' with condensed separated nuclei. (d) DNA fragmentation of U937 cells with or without GM-CSF. U937 cells were cultivated as described above and then small molecular weight DNA was extracted. The existence of internucleosomal DNA was examined by agarose gel electrophoresis.
Figure 2
Combined effects of GM-CSF and TNF on U937 cells. U937 cells were cultivated with or without 10 ng/ml GM-CSF, 10 ng/ml TNF or combination of both for 2 days (48 h), and then subjected to FACS analysis to quantify the population in the sub-G1 region.
Figure 3
Growth curves of U937 cells. U937 cells were cultivated with or without 10 ng/ml GM-CSF, 10 ng/ml TNF or combination of both for up to 96 h (4 days). The cells were harvested every 24 h and a viable cell count was performed using trypan blue dye exclusion method. The data are expressed as means ± s.d. of three to five experiments.
No effects of caspase inhibitors on GM-CSF-induced apoptosis
To clarify the roles of caspase 3-like activity in apoptosis induced by the two cytokines, we investigated the effect of YVAD-CMK (an inhibitor of caspase 1 and its family of caspases), DEVD-CHO (an inhibitor of caspase 3 and its family of caspases) and z-VAD-FMK (a broad spectrum caspase inhibitor) on apoptosis induced by GM-CSF and TNF. As shown in Figure 6 , YVAD-CMK, DEVD-CHO and z-VAD-FMK potently inhibited TNF-induced apoptosis, whereas these inhibitors did not affect GM-CSF-induced apoptosis.
Production of cleaved forms of caspase 3 protein by cytokine stimulation
To determine whether caspase 3 itself was activated during the stimulation with cytokines, we performed Western blotting of caspase 3 by using a monoclonal antibody specific for caspase 3. As reported previously, precursor polypeptide of caspase 3 with 32 kDa (p32) has two cleavage sites, and complete enzymatic processing produces three polypeptides, 3 kDa N-terminal pro-domain, 17 kDa subunit (p17) and 12 kDa subunit (p12). 2, 3 It is also possible that single site cleavage produces 29 kDa (17 + 12 kDa) and/or 20 kDa (3 + 17 kDa) polypeptides (p29 and p20). As shown in Figure 7 , these cleaved forms of caspase 3 (p29, p20 and p17) were observed when the cells were stimulated with TNF for 2 days (48 h). No visualization of p12 and 3-kDa pro-domain indicates that the epitope recognized by this monoclonal antibody is localized within p17. In contrast, GM-CSF induced minimal (but significant) production of these cleaved forms at 2 days. Combined stimulation cells with both cytokines for 2 days did not induce synergistic productions of cleaved forms and resulted in the effect of TNF alone. These findings were partly compatible to, but considerably dissociated from, the results for caspase 3-like activity (Figure 4) showing detectable caspase 3-like activity by GM-CSF alone and its synergism with TNF.
At 4 days (96 h) of incubation, cleaved forms of caspase 3 and caspase 3-like activity concomitantly decreased (returned to almost baseline level) when the cells were stimulated with TNF (Figures 4 and 7) . Surprisingly, cleaved forms of caspase 3 were also undetectable at this period in GM-CSF-stimulated cells (Figure 7) , when the activity reached high level (Figure 4 ). In addition, combined stimulation of cells with both Caspase 3-like protease activity in U937 cells. U937 cells were cultivated with or without 10 ng/ml GM-CSF, 10 ng/ml TNF or combination of both for up to 96 h (4 days). Caspase 3-like activity was measured with DEVD-AMC as substrate at each time point. The data are expressed as means of triplicate determinations and the standard deviations were always less than 5% of corresponding mean values.
Figure 5
Effects of caspase inhibitors on caspase 3-like activity in U937 cells stimulated by GM-CSF. U937 cells were cultivated with 10 ng/ml GM-CSF for 4 cytokines did induce highly synergistic enzymatic activity (Figure 4 ) without detectable cleaved forms (Figure 7) .
These findings indicate apparent discrepancy between caspase 3-like activity and active forms of caspase 3 protein in GM-CSF-stimulated cells, and strongly suggest that caspase 3-like activity induced by GM-CSF was not caspase 3 itself.
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Figure 6
Effects of caspase inhibitors on apoptosis of U937 cells. U937 cells were cultivated with 10 ng/ml TNF for 1 day or 10 ng/ml GM-CSF for 4 days in the presence or absence of 0.2% DMSO ( 
Figure 7
Western blot analysis of caspase 3 in U937 cells. U937 cells were cultivated with or without 10 ng/ml GM-CSF, 10 ng/ml TNF or combination of both for 2 and 4 days. After solubilization, cell lysates were subjected to immunoprecipitation by anti-caspase 3 antibody followed by Western blotting by the same antibody.
Involvement of caspases other than caspase 3
Caspases are classified into three groups: those for cytokine activation, those for apoptosis initiation and those for apoptosis execution. 3 We selected caspases 1, 8 and 7 from three groups, respectively, and studied their possible involvement in GM-CSF signaling. As shown in Table 1 , GM-CSF induced caspase 1-and 8-like activities in addition to caspase 3-like activity. Cleaved forms of caspase 8 (p43 and p18) were also detected in cells stimulated with GM-CSF and cytokine Table 1 Caspase activities induced by GM-CSF in U937 cells combination (Figure 8 ). On the other hand, cleaved form of caspase 1 was not induced by any stimulus including GM-CSF and TNF (blots are not shown). GM-CSF neither induced caspase 7-like activity (Table 1 ) nor produced cleaved forms of caspase 7 (blots are not shown) at 4 days when unknown caspase 3-like activity was maximal, suggesting GM-CSFinduced caspase 3-like activity was not caspase 7.
Discussion
In the present study, we identified time-and dose-dependent apoptosis-inducing effects of GM-CSF on human hematopoietic U937 cells. This effect was resistant to the specific inhibitor of caspase 3 and we could not detect immuno-reactive active forms of caspase 3 by GM-CSF in spite of high enzy-
Figure 8
Western blot analysis of caspase 8 in U937 cells. U937 cells were cultivated with or without 10 ng/ml GM-CSF, 10 ng/ml TNF or combination of both for 4 days. After solubilization, cell lysates were subjected to Western blotting by anti-caspase 8 antibody.
matic activity for the caspase 3-specific substrate. This caspase 3-like activity induced by GM-CSF interacted highly synergistically with caspase 3 activity induced by TNF. These findings together suggest induction of apoptosis by GM-CSF via unknown caspase 3-like mechanism in human hematopoietic cells. To our knowledge, this is the first demonstration of caspase-like, but not itself a mechanism for apoptosis induced by physiological cytokines.
Effects of GM-CSF on U937 cells have been so far focused on differentiation and/or growth suppression rather than proliferation, [12] [13] [14] and there are no reports regarding the apoptosis-inducing effects of this cytokine. There is rather a report describing the apoptosis-inhibiting effects of GM-CSF on U937 cells. 15 Differentiation-inducing effects of GM-CSF alone on U937 cells is not always prominent and sometimes undetectable. 13 We also found that U937 cells did not undergo differentiation in response to GM-CSF as determined by superoxide-producing capacity; at least the clone of this cell line in our laboratory was used. Nevertheless, as shown in this study, U937 cells showed apparent growth inhibition and apoptosis in response to GM-CSF. In addition, GM-CSFinduced apoptosis was confirmed by three independent methods, FACS analysis, morphological examination and DNA ladder formation.
Signaling pathways after GM-CSF receptors has been mainly focused on kinase cascades such as Jak2-Stat5 and Ras-Raf-ERK pathways. 6, 7 In fact, we confirmed that these pathways are really activated in U937 cells stimulated by GM-CSF (data not shown), although these signaling molecules have been proposed to contribute anti-apoptotic and/or proliferative but not apoptotic effects of GM-CSF. 6, 7 Several but not many investigators have reported activation of p38 kinase, an apoptosis-inducing signaling molecule, by GM-CSF in hematopoietic cells. 16, 17 In U937 cells, however, we could not detect tyrosine phosphorylation of p38 under the condition that TNF potently did this, and a specific inhibitor of p38 (SB203580) did not attenuate GM-CSF-induced apoptosis (unpublished observations).
TNF is known to induce apoptosis in many kinds of cells including hematopoietic cells via step-wise activation of intracellular cascade of several members of the caspase family of proteases. 2, 3 Among the caspases, caspase 3 is the most critical and distal caspase which directly activates the DNase responsible for the DNA ladder formation. 4 We observed that caspase 3 activity determined by enzyme assay and immunoreactive active forms of caspase 3 identified by immunoblotting increased or decreased in parallel after the stimulation of cells with TNF. This finding is consonant to the idea that observed activity induced by TNF reflects caspase 3 itself. In contrast, enzymatic activity and amount of active, cleaved enzyme did not correlate in GM-CSF-stimulated cells. This finding strongly suggests that caspase 3-like activity induced by GM-CSF is not caspase 3 itself. Although we could not determine causal relationship between the activation of this caspase 3-like unknown protease and GM-CSF-induced apoptosis, the time courses of enzymatic activation and apoptosis induced by GM-CSF were identical. In addition, HL-60 cells, which do not undergo apoptosis in response to GM-CSF, did not show any detectable increase in caspase 3-like activity by the same cytokine (unpublished observation).
GM-CSF induced minimal but significant cleavage of caspase 3 at 2 days (Figure 7) , when minimal but significant caspase 3-like activity was detected in GM-CSF-stimulated cells (Figure 4) . The cleaved form of caspase 3 disappeared at 4 days ( Figure 7 ). These findings suggest that GM-CSF might activate, in addition to unknown caspase-like pathway, the conventional caspase 3 cascade to some extent. This conventional cascade, however, does not contribute to apoptosis, since conventional caspase inhibitors including a specific inhibitor of caspase 3 did not affect GM-CSF-induced apoptosis ( Figure 6 ). In addition, highly synergistic induction of apoptosis and caspase 3-like activity was observed by the combination of TNF and GM-CSF at 4 days (Figures 3 and 4) , when cleaved forms of caspase 3 was not detected by cytokine combination (Figure 7) .
Current investigation provides evidence for activation of caspase 3-like unknown molecules during the apoptosis induced by cytokine in human hematopoietic cells. There are already many (more than 10) caspases isolated and different caspases could contribute to various kinds of apoptosis in a specific manner. 2, 3 These caspases are classified into three groups; those for cytokine activation (caspases 1, 4 and 5), those for apoptosis initiation (caspases 2, 8, 9, and 10) and those for apoptosis execution (caspases 3, 6 and 7). 3 We selected three representative caspases, caspases 1, 8 and 7, from each group and studied their possible involvement in GM-CSF signaling, since (1) GM-CSF seems to utilize caspase 1-like YVADase (Figures 5); (2) Caspase 8 is a well-known standard initiator caspase which could activate caspase 3 and the other effector caspases;
2,3 and (3) caspase 7 is another important effector caspase capable of cleaving DEVD sequence. 3 Results show involvement of caspase 8-like activity with cleaved caspase 8 and caspase 1-like activity without its cleaved form. Involvement of caspase 7 was unlikely, based upon absence of both activity and cleaved protein. It is also possible that (known or unknown) intracellular molecules other than caspases (such as apoptosis-inducing factor 18 ) are involved in the caspase cascade in U937 cells stimulated by GM-CSF. Precise nature and overall design of the intracellular mechanism for cell death triggered by GM-CSF in human hematopoietic cells must await further investigation.
